- Home
- PLUR vs GIFT Comparison
PLUR vs GIFT Comparison
Compare PLUR & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUR
- GIFT
- Stock Information
- Founded
- PLUR 2001
- GIFT 1999
- Country
- PLUR Israel
- GIFT United States
- Employees
- PLUR N/A
- GIFT N/A
- Industry
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- GIFT Catalog/Specialty Distribution
- Sector
- PLUR Health Care
- GIFT Consumer Discretionary
- Exchange
- PLUR Nasdaq
- GIFT Nasdaq
- Market Cap
- PLUR 36.9M
- GIFT 33.9M
- IPO Year
- PLUR N/A
- GIFT N/A
- Fundamental
- Price
- PLUR $3.91
- GIFT $1.14
- Analyst Decision
- PLUR Strong Buy
- GIFT Strong Buy
- Analyst Count
- PLUR 1
- GIFT 1
- Target Price
- PLUR $12.00
- GIFT $4.00
- AVG Volume (30 Days)
- PLUR 10.5K
- GIFT 115.7K
- Earning Date
- PLUR 11-11-2025
- GIFT 11-13-2025
- Dividend Yield
- PLUR N/A
- GIFT N/A
- EPS Growth
- PLUR N/A
- GIFT N/A
- EPS
- PLUR N/A
- GIFT N/A
- Revenue
- PLUR $1,336,000.00
- GIFT $90,569,384.00
- Revenue This Year
- PLUR $97.38
- GIFT $5.90
- Revenue Next Year
- PLUR $293.97
- GIFT $13.45
- P/E Ratio
- PLUR N/A
- GIFT N/A
- Revenue Growth
- PLUR 309.82
- GIFT 8.55
- 52 Week Low
- PLUR $3.33
- GIFT $0.82
- 52 Week High
- PLUR $7.13
- GIFT $2.38
- Technical
- Relative Strength Index (RSI)
- PLUR 41.69
- GIFT 54.56
- Support Level
- PLUR $3.60
- GIFT $1.05
- Resistance Level
- PLUR $4.09
- GIFT $1.22
- Average True Range (ATR)
- PLUR 0.18
- GIFT 0.07
- MACD
- PLUR -0.02
- GIFT 0.01
- Stochastic Oscillator
- PLUR 30.69
- GIFT 57.89
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
About GIFT RDE Inc. Common Stock
Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.